PMGC Holdings ELAB
NASDAQ ELAB
$4.70 +0.08 (+1.72%)
As of: Sep 10, 2026 · 12:55 PM EDT

PMGC Holdings (ELAB) Operating Income (2022 - 2026)

PMGC Holdings' (ELAB) quarterly Operating Income came in at -$3.8 million in Q2 2026, down 14.82% quarter-over-quarter from -$3.3 million in Q1 2026.

Analysis

PMGC Holdings (ELAB) Operating Income (2022 - 2026) Analysis & Trends

PMGC Holdings has disclosed Operating Income across 5 years of filings, most recently posting -$3.8 million for Q2 2026.

  • In Q2 2026, Operating Income changed N/A year-over-year to -$3.8 million; the TTM figure through Jun 2026 stood at -$11.9 million (changed N/A YoY), while the FY2025 annual figure was -$6.9 million, changed N/A from the prior year.
  • Operating Income came in at -$3.8 million for Q2 2026 at PMGC Holdings, down from -$3.3 million in the prior quarter.
  • In the past five years, Operating Income ranged from a high of $1.1 billion in Q4 2022 to a low of -$471.8 million in Q3 2022.
  • Average Operating Income over 5 years is $48.0 million, with a median of -$1.4 million recorded in 2024.
  • Year-over-year, Operating Income jumped 99.83% in 2023 and slumped 139.05% in 2025.
  • Over 5 years, Operating Income stood at $1.1 billion in 2022, then tumbled by 100.1% to -$1.1 million in 2023, then climbed by 14.9% to -$919837.0 in 2024, then slumped by 173.05% to -$2.5 million in 2025, then sank by 52.38% to -$3.8 million in 2026.
  • Per Business Quant data, the three most recent Operating Income figures were -$3.8 million in Q2 2026, -$3.3 million in Q1 2026, and -$2.5 million in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Op. Inc (Qtr)
1 Amgen 206.09 Bn 192.10 Bn 7.24 Bn 3.51 Bn
2 Gilead Sciences 179.75 Bn 176.57 Bn 6.22 Bn -10.39 Bn
3 Vertex Pharmaceuticals 131.11 Bn 123.26 Bn 2.84 Bn 1.25 Bn
4 Regeneron Pharmaceuticals 81.77 Bn 73.78 Bn 3.93 Bn 1.29 Bn
5 Argenx Se 60.45 Bn 55.27 Bn 1.37 Bn 493.00 Mn
6 Moderna 53.60 Bn 48.46 Bn 52.00 Mn -815.00 Mn
7 Alnylam Pharmaceuticals 33.36 Bn 30.06 Bn 992.69 Mn 231.44 Mn
8 Biogen 31.72 Bn 30.44 Bn 1.96 Bn -644.50 Mn
9 Roivant Sciences 29.09 Bn 29.09 Bn 1.16 Mn -365.99 Mn
10 PMGC Holdings 2.29 Mn -16.50 Mn 385,691.00 -3.83 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -3.83 Mn
Mar 31, 2026 -3.33 Mn
Dec 31, 2025 -2.51 Mn
Sep 30, 2025 -2.20 Mn
Sep 30, 2024 -919,837.00
Jun 30, 2024 -1.41 Mn
Mar 31, 2024 -1.68 Mn
Dec 31, 2023 -1.08 Mn
Sep 30, 2023 -785,551.00
Jun 30, 2023 -1.05 Mn
Mar 31, 2023 -846,389.00
Dec 31, 2022 1.12 Bn
Sep 30, 2022 -471.84 Mn